Cargando…
Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease
The aggregation of amyloid-β peptide (Aβ) has been linked to the formation of neuritic plaques, which are pathological hallmarks of Alzheimer’s disease (AD). Various natural compounds have been suggested as therapeutics for AD. Among these compounds, resveratrol has aroused great interest due to its...
Autores principales: | Loureiro, Joana A., Andrade, Stephanie, Duarte, Ana, Neves, Ana Rute, Queiroz, Joana Fontes, Nunes, Cláudia, Sevin, Emmanuel, Fenart, Laurence, Gosselet, Fabien, Coelho, Manuel A. N., Pereira, Maria Carmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155722/ https://www.ncbi.nlm.nih.gov/pubmed/28208831 http://dx.doi.org/10.3390/molecules22020277 |
Ejemplares similares
-
Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E
por: Neves, Ana Rute, et al.
Publicado: (2016) -
TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
por: Versele, Romain, et al.
Publicado: (2022) -
Ketone Bodies Promote Amyloid-β(1–40) Clearance in a Human in Vitro Blood–Brain Barrier Model
por: Versele, Romain, et al.
Publicado: (2020) -
The Blood–Brain Barrier, an Evolving Concept Based on Technological Advances and Cell–Cell Communications
por: Menaceur, Camille, et al.
Publicado: (2021) -
Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
por: Andrade, Stephanie, et al.
Publicado: (2018)